周玉美, 崔华清, 俞晓明, 张首国, 彭涛, 王刚, 温晓雪, 孙云波, 刘曙晨, 王林. 苯并咪唑和苯并噻唑类衍生物的合成及其sirtuins抑制活性评价J. 药学学报, 2017,52(5): 773-778. doi: 10.16438/j.0513-4870.2017-0180
引用本文: 周玉美, 崔华清, 俞晓明, 张首国, 彭涛, 王刚, 温晓雪, 孙云波, 刘曙晨, 王林. 苯并咪唑和苯并噻唑类衍生物的合成及其sirtuins抑制活性评价J. 药学学报, 2017,52(5): 773-778. doi: 10.16438/j.0513-4870.2017-0180
ZHOU Yu-mei, CUI Hua-qing, YU Xiao-ming, ZHANG Shou-guo, PENG Tao, WANG Gang, WEN Xiao-xue, SUN Yun-bo, LIU Shu-chen, WANG Lin. Synthesis of benzimidazole and benzothiazole derivatives as a sirtuins 2 inhibitorJ. Acta Pharmaceutica Sinica, 2017,52(5): 773-778. doi: 10.16438/j.0513-4870.2017-0180
Citation: ZHOU Yu-mei, CUI Hua-qing, YU Xiao-ming, ZHANG Shou-guo, PENG Tao, WANG Gang, WEN Xiao-xue, SUN Yun-bo, LIU Shu-chen, WANG Lin. Synthesis of benzimidazole and benzothiazole derivatives as a sirtuins 2 inhibitorJ. Acta Pharmaceutica Sinica, 2017,52(5): 773-778. doi: 10.16438/j.0513-4870.2017-0180

苯并咪唑和苯并噻唑类衍生物的合成及其sirtuins抑制活性评价

Synthesis of benzimidazole and benzothiazole derivatives as a sirtuins 2 inhibitor

  • 摘要: 设计合成新型结构sirtuins抑制剂并评价其对SIRT1~SIRT3的抑制活性。基于已报道的sirtuins抑制剂结构和药效团特征,设计了一系列苯并咪唑和苯并噻唑类化合物。以乙基黄原酸钾为起始原料,经3步反应合成了16个未见文献报道的目标化合物,目标化合物的结构经1H NMR、HR-MS确证。对目标化合物进行SIRT1~SIRT3的抑制活性评价,其中苯并咪唑类化合物对SIRT2具有选择性的抑制活性。

     

    Abstract: A series of novel benzimidazole and benzothiazole derivatives were designed and synthesized as inhibitors of SIRT1-SIRT3. The target compounds were synthesized from potassium O-ethyldithiocarbonate through a three-step route. The structures of the obtained compounds were elucidated by 1H NMR and HR-MS. Of all compounds, six showed potent SIRT2-inhibitory activities with IC50 values ranging from 2.8 to 21.2 μmol·L-1. Among them, compound 10c displayed the most potent SIRT2-inhibitory activities (IC50 = 2.8 μmol·L-1), with more than 35-fold selectivity over SIRT1 and SIRT3 (IC50>100 μmol·L-1).

     

/

返回文章
返回